The Certara Blog

Author: Mark Reimer

Dr. Reimer leads a highly skilled team of clinical pharmacologists, pharmacometricians, biostatisticians, and medical writers who are committed to providing high-quality, regulatory-compliant PK/PD analysis and reporting services for the pharma/biotech industry. He is an experienced leader in the development of new drug therapies with over twenty-five years of progressive scientific, managerial and executive responsibilities in the field of drug research, including ADME/T and bioanalysis. His experience includes the design, execution and interpretation of a wide variety of preclinical services used in the pharmaceutical and biotechnology industries to bring new molecular entities through the drug development process. He led preclinical research efforts at Theratechnologies, a major Canadian biopharmaceutical company, and was responsible for the inception, build-out, and consistent profitability of the drug metabolism unit at MDS Pharma Services, at the time one of the world’s top-five contract research organizations. Dr. Reimer earned a PhD in chemistry at the University of Manitoba and completed a post-doctoral fellowship at the College of Pharmacy of the University of Arizona.

Recent Posts

Pill with Canadian flag on it

Highlights of the Quebec “Drug Discovery to Development” Symposium

In today’s drug development climate, we’re encouraged to “think global, act local.” I have had the privilege of supporting the development of important new therapies for clients around the globe. But sometimes, it is helpful to take a step back and look at the exciting science going on in your own backyard. With that spirit […]

Read More
Learn More LinkedIn Twitter Facebook Email Subscribe to the Blog